Published • loading... • Updated
West Pharmaceutical: Q2 Earnings Snapshot
West Pharmaceutical said revenue of $872.3 million topped estimates and it forecast higher earnings and sales for the fiscal third quarter and full year.
Summary by Washington Top News
4 Articles
4 Articles
West Reports Second-Quarter 2026 Results - PressReach
Raising Full-Year Net Sales and EPS guidance EXTON, Pa., July 23, 2026 /PRNewswire/ — West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026. Second-Quarter Summary (comparisons to prior-year period) Net sales of $872.3 million increased 13.8%; organic growth was 12.7%. Diluted earnings per share (“EPS…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right1Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
C 67%
R 33%
Factuality
To view factuality data please Upgrade to Premium
